{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:40:39Z","timestamp":1792633239546,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.joca.2020.01.012","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T02:23:16Z","timestamp":1580696596000},"page":"486-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-3524","authenticated-orcid":false,"given":"K.M.-C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-2338","authenticated-orcid":false,"given":"A.","family":"Achuthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6803-3533","authenticated-orcid":false,"given":"A.J.","family":"Fleetwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.joca.2020.01.012_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.joca.2020.01.012_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","article-title":"Therapeutic options for targeting inflammatory osteoarthritis pain","volume":"15","author":"Conaghan","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.joca.2020.01.012_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","article-title":"A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis \u2013 the HUMOR trial","volume":"26","author":"Aitken","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.joca.2020.01.012_bib4","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar3430","article-title":"A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.joca.2020.01.012_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.joca.2020.01.012_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1759720X17752036","article-title":"Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-alpha in rheumatoid arthritis: focus on mavrilimumab","volume":"10","author":"Cook","year":"2018","journal-title":"Therapeut Adv Muscoskel Dis"},{"issue":"5","key":"10.1016\/j.joca.2020.01.012_bib7","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/ar4037","article-title":"Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development","volume":"14","author":"Cook","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2020.01.012_bib8","first-page":"70","article-title":"A\u00a0phase IIa study of anti-GM-CSF antibody GSK3196165 in subjects with inflammatory hand osteoarthritis [abstract]","author":"Schett G","year":"2018","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.joca.2020.01.012_bib9","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI87828","article-title":"Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation","volume":"126","author":"Achuthan","year":"2016","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.joca.2020.01.012_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-018-1560-9","article-title":"CCL17 blockade as a therapy for osteoarthritis pain and disease","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.joca.2020.01.012_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/annrheumdis-2012-201703","article-title":"Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain","volume":"72","author":"Cook","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2020.01.012_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1744-8069-9-57","article-title":"Chemokine expression in peripheral tissues from the monosodium iodoacetate model of chronic joint pain","volume":"9","author":"Dawes","year":"2013","journal-title":"Mol Pain"},{"issue":"9","key":"10.1016\/j.joca.2020.01.012_bib13","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/jor.23909","article-title":"Meniscal extrusion and degeneration during the course of osteoarthritis in the murine collagenase-induced osteoarthritis model","volume":"36","author":"Utomo","year":"2018","journal-title":"J Orthop Res"},{"issue":"3","key":"10.1016\/j.joca.2020.01.012_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.joca.2016.09.009","article-title":"Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis","volume":"25","author":"van Dalen","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"10.1016\/j.joca.2020.01.012_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrrheum.2013.44","article-title":"Biologic agents in osteoarthritis: hopes and disappointments","volume":"9","author":"Chevalier","year":"2013","journal-title":"Nat Rev Rheumatol"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458420300431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458420300431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:52:33Z","timestamp":1761018753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458420300431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1063458420300431"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2020.01.012","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2020.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}